top of page
Soft Launching (beta) ahead of clinical pilot. Early access to Device Request and Dashboard
Enabling Connected Care at Home
Lab-in-Bathroom
A state-of-the-art passive urine monitoring technology for at-home cardiovascular disease management, and more.
• Non-invasive and non-intrusive
• Multi-user with authentication
Important: Unephra is a Non-Significant Risk (NSR) investigational device, not yet cleared by FDA.
Supported by
and
About
Unephra enables at-home cardiovascular disease management by integrating personalized cardio-renal physiology into treatment. Our proprietary passive urine-monitoring technology turns every bathroom visit into real-time clinical insights shared between care teams and patients. This empowers healthcare providers to deliver proactive, tailored interventions that improve outcomes while reducing the cost of care.
Our Mission
Improving Quality of Care and Life Through Innovative Technology
Our Focus
At-Home Personalized Health Monitoring and Care for Heart Failure & Hypertensive Patients
Our Goal
Preventing Avoidable Hospitalizations while Reducing Patients Risk
Our Vision
A Future Where Personalized Health is More Accessible, Effortless and Effective
Our Values
Innovation, Quality, and Customer & User Centric Design
Proprietary Technology
Unephra sensing technology enables continuous monitoring of health and disease risks. It provides actionable insights for both care teams and patients based on personalized cardio-renal physiology and advanced urine analysis
Personalized Risk Assessment
Based on Cardio-Renal Physiological Model
Informed Data Processing
Advanced Machine Learning and Statistical Analysis
Smart Bio-Chemical Sensing
Adaptive Micro-Sensor Array for Urine Biomarker Measurement
Clients
Our Valued Customers and Partners
Permanente Medicine
Snyder Lab | Stanford
KeborMed
What Experts Say About Unephra
bottom of page